Patents by Inventor Saivishal DARIPELLI

Saivishal DARIPELLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment with histamine-3 receptor inverse agonist
    Patent number: 11622967
    Abstract: The present invention provides new methods of treatment for narcolepsy, excessive daytime sleepiness, obstructive sleep apnea, circadian rhythm sleep disorders, sleep and vigilance disorders associated with Parkinson's disease, multiple sclerosis, dementia or attention deficit hyperactivity disorder by administering a therapeutically effect amount of histamine-3 receptor (H3R) inverse agonist, N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide or a pharmaceutically acceptable salt thereof. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: April 11, 2023
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Vijay Sidram Benade, Saivishal Daripelli, Pradeep Jayarajan, Jyothsna Ravula, Venkateswarlu Jasti
  • Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators
    Patent number: 11234979
    Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs).
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: February 1, 2022
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Srinivas Ravella, Vanaja Middekadi, Vinod Kumar Goyal, Pradeep Jayarajan, Saivishal Daripelli, Venkateswarlu Jasti
  • METHOD OF TREATMENT WITH HISTAMINE-3 RECEPTOR INVERSE AGONIST
    Publication number: 20210213026
    Abstract: The present invention provides new methods of treatment for narcolepsy, excessive daytime sleepiness, obstructive sleep apnea, circadian rhythm sleep disorders, sleep and vigilance disorders associated with Parkinson's disease, multiple sclerosis, dementia or attention deficit hyperactivity disorder by administering a therapeutically effect amount of histamine-3 receptor (H3R) inverse agonist, N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide or a pharmaceutically acceptable salt thereof. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
    Type: Application
    Filed: August 1, 2018
    Publication date: July 15, 2021
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Vijay Sidram BENADE, Saivishal DARIPELLI, Pradeep JAYARAJAN, Jyothsna RAVULA, Venkateswarlu JASTI
  • HETEROARYL COMPOUNDS AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
    Publication number: 20200237761
    Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
    Type: Application
    Filed: October 17, 2018
    Publication date: July 30, 2020
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Abdul Rasheed Rasheed MOHAMMED, Anil Karbhari SHINDE, Srinivas RAVELLA, Vanaja MIDDEKADI, Vinod Kumar GOYAL, Pradeep JAYARAJAN, Saivishal DARIPELLI, Venkateswarlu JASTI